Bioscience Equity Partners
Venture capitalDubai Β· Late Stage Β· 1 people tracked
Investment thesis
The firm operates two divisions under one institutional standard. Its life sciences division structures, anchors, and executes capital rounds for biotechnology, medical technology, and digital health companies, with affiliated fund Antisoma anchoring roughly half of each round and the remainder syndicated across a consortium of sovereign and quasi-sovereign funds in the GCC and Asia. Its infrastructure and sovereign advisory division structures and executes infrastructure-grade transactions for governments, ministries, sovereign funds, and state-owned enterprises across energy (including nuclear/SMRs), agricultural biotech, and defence-adjacent manufacturing. The firm runs each mandate from origination to close and engages only with counterparties known to its consortium.
Source: firm website, verified Aug 3, 2026.
Team Β· 1 people
from the firm's websiteGeorge Syrmalis is an MD and PhD-qualified nuclear medicine physician and scientist who moved from clinical science and academia into entrepreneurship and venture capital. He founded and led multiple biotechnology companies, taking several from discovery to public listing, and is Founder and CEO of Bioscience Equity Partners. He now focuses on providing venture capital to early-stage biotech and med-tech ventures globally.
Frequently asked questions
- What stage does Bioscience Equity Partners invest at?
- Bioscience Equity Partners invests at the Late Stage stage.
- What sectors does Bioscience Equity Partners focus on?
- Bioscience Equity Partners focuses on Advanced Manufacturing, AgTech, Biotech, Defense Tech, Digital Health, Energy, Healthtech, Longevity, Medical Devices.
- Where is Bioscience Equity Partners located?
- Bioscience Equity Partners is headquartered in Dubai, AE.
Media Β· Podcasts & interviews
featuring the teamInside the Mind of a Global Biotech Investor: Dr. George Syrmalis, CEO, Bioscience Equity Partners - YouTube
Analyzing Healthcare by SCALE Community Β· George Syrmalis
Images
Similar investors
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
LIFTT is an early-stage venture capital investor that backs deep tech startups from pre-seed and seed onward, providing capital alongside managerial coaching, governance support and access to an international network. It operates the LIFTT EuroInvest vehicle in partnership with the European Investment Bank.
Overwater Ventures is an early-stage investor backing companies redefining everyday experiences, investing at pre-seed and seed stages.
Everywhere Ventures is a global pre-seed venture capital firm founded in 2018 and headquartered in New York, investing $250,000 into early-stage technology companies. It runs a community-led model backed by 500+ founder and operator LPs.
Brookstreet Equity Partners is an award-winning investment platform founded by shipping and principal-capital families, deploying hybrid growth capital across multiple stages, markets, regions, and instruments with a focus on ROCE and DPI.